Another WHO criminal, who has recently been pushing more vaccine doses, comes from Imperial College (like her former boss Prof. Neil Ferguson and the former head of MI5 who was Imperial's Chair)

Interesting how there are so few MDs at the top of the WHO. She was in Cambodia when Farrar was in Vietnam. She is in a network. A fixer, not a scientist.

Dr Maria D Van Kerkhove, PhD

Faculty of Medicine, School of Public Health

But before I give you Maria’s bio, I want to mention a true top leader of the global putsch, of whom few are aware.

Baroness Eliza Manningham-Buller

Baroness Eliza Manningham Buller was head of MI5, then moved to head Imperial College, then moved to chair the Wellcome Trust, where she was Sir Dr. Jeremy Farrar’s (007, License to Overdose) boss. She is also currently President of Chatham House. She seems to be a highly competent individual.

I am slowly providing a rogues’ gallery because you can see that the other side really does not have that many people to insert into influential positions at the WHO, Wellcome Trust, UK health leadership, etc. (Maria van Kerkhove is not that bright but she is good at following orders and play-acting.) So the same people keep being moved around. This should give you a good feeling—they are not as numerous or strong as they would have us believe. And we know who many of them are, and we can map their networks. Try your hand at this.

Now back to Maria—below is her bio from Imperial College. Note the history of avian flu work.

Summary

Maria Van Kerkhove holds an honorary lecturer position at Imperial College after leaving the college in January 2015 to join the Center for Global Health at Institut Pasteur as the Head of their Outbreak Investigation Task Force. 

While at Imperial College, Maria Van Kerkhove served as a senior research fellow in the MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology at Imperial College London and a Technical Consultant for the Global Capacities, Alert and Response Cluster of the World Health Organization (WHO).  Dr Van Kerkhove remains a technical consultant for WHO.

Dr. Van Kerkhove served as the liaison between the World Health Organization (WHO) and the MRC Centre for Outbreak Analysis and Modelling. In this role, she developed projects to support WHO activities and policy decision making for influenza, Middle East respiratory syndrome coronavirus (MERS-CoV), yellow fever, Ebola and other emerging diseases. She and Centre staff continue to provide technical assistance to WHO (including to the Global Influenza Programme, the Pandemic and Epidemic Diseases Department, Initiative for Vaccine Research department and the Global Outbreak Alert and Response Network) through the interpretation of available global data, in collaboration with WHO’s member states, regional and country offices and internationally renowned scientists. The centre provides technical support in the areas of influenza, MERS-CoV, polio, malaria, yellow fever, cholera, hepatitis, HIV and meningitis.

Dr Van Kerkhove is also a member of the WHO Task Force for MERS-CoV.  Her work involves providing WHO with epidemiologic and statistical support for the analysis and interpretation of MERS-CoV data for risk assessments, web-based summaries and communications; the development of epidemiologic and serologic investigation protocols for MERS-CoV; and other publications on topics related MERS-CoV.

During the 2009 H1N1 influenza pandemic, Dr. Van Kerkhove worked directly with WHO’s Global Alert and Response and Global Influenza Programme to support the pandemic response. Her main activity during the pandemic was to coordinate the WHO informal mathematical modelling network for H1N1pdm under the leadership of Professor Neil Ferguson and Dr. Cathy Roth (WHO), which included more than 40 Individuals from public health and academic organizations from around the world. 

CONSISE

In addition to this liaison role with WHO, Dr. Van Kerkhove is a leading member of  CONSISE (the Consortium for the Standardization of Influenza Seroepidemiology), which is a global partnership aiming to develop influenza investigation protocols and standardize seroepidemiology to inform health policy. This international partnership was formed in 2011 and was created out of a need, identified during the 2009 H1N1 pandemic, for timely seroepidemiological data to better estimate pandemic virus infection severity and attack rates to inform policy decisions.

CONSISE has developed into a consortium of two interactive working groups: epidemiology (for which Maria leads) and laboratory (co-lead by John Wood and Othmar Engelhardt of NIBSC), with a steering committee composed of individuals from several organizations includingthe World Health Organization, the US Centres for Disease Control and Prevention, the European Centres for Disease Control, Public Health England (Formerly the UK Health Protection Agency), Imperial College London, the WHO Collaborating Centre for Reference and Research on Influenza (Melbourne, Australia), University of Hong Kong, Oxford University Clinical Research Unit in Hanoi, and Public Health Agency of Canada.  CONSISE has held four international meetings (February 2011 in Ottawa Canada, December 2011 in Stockholm Sweden, January 2013 in Hong Kong, SAR, and September 2013 in Cape Town, South Africa).

More information about CONSISE can be found here and in the publications below.

Prior to the 2009 pandemic

Prior to 2009, Dr Van Kerkhove's research focus was highly pathogenic avian influenza H5N1 (HPAI/H5N1).  This research was conducted in Cambodia in collaboration with the Ministry of Agriculture, Fisheries and Forestry (NAVRI), Institut Pasteur du Cambodge and London School of Hygiene and Tropical Medicine, and involved the collection of novel field data in rural, peri-urban and urban areas of Cambodia to better understand the risks of transmission of HPAI/H5N1 from poultry to humans and the potential circulation of HPAI via live poultry trade. Her PhD thesis is available here.

Dr Van Kerkhove holds a Ph.D. in infectious disease epidemiology from the London School of Hygiene and Tropical Medicine, a M.S. in Epidemiology from Stanford University, and a B.S. in Biological Sciences from Cornell University.